70 related articles for article (PubMed ID: 24739717)
1. [Liver and heart iron deposition status in patients with β thalassemia major: a multicenter study].
Li C; Liu S; Wang Y; Wen F; Gao H; Chen G; Li C; Wu X; Fang J; Hao W; Liu R; Zhang X; Chu CW; Au W
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):90-3. PubMed ID: 24739717
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging assessment of the changes of cardiac and hepatic iron load in thalassemia patients before and after hematopoietic stem cell transplantation.
Xu F; Li D; Tang C; Liang B; Guan K; Liu R; Peng P
Sci Rep; 2023 Nov; 13(1):19652. PubMed ID: 37950037
[TBL] [Abstract][Full Text] [Related]
4. Pattern and clinical correlates of renal iron deposition in adult beta-thalassemia major patients.
Meloni A; Barbuto L; Positano V; Pistoia L; Spasiano A; Casini T; Massei F; Argento C; Giovangrossi P; Barone A; Romano L; Cademartiri F
Clin Exp Med; 2023 Nov; 23(7):3573-3579. PubMed ID: 37433990
[TBL] [Abstract][Full Text] [Related]
5. [Study of iron overload assessment by T2* magnetic resonance imaging in patients with myelodysplastic syndromes].
Song LL; Lu HY; Xiao C; Wu LY; Wu D; Su JY; Zhou LY; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):222-226. PubMed ID: 30929390
[No Abstract] [Full Text] [Related]
6. The Effect of Iron Overload on the Mobilization of Peripheral Blood Hematopoietic Stem Cells in Pediatric Patients with Thalassemia Major.
Van Timothee BM; Du J; Ren Y; He Y; Ruan Y; Liu X; Chen L; Wen J; Ding R; Yu L; Liu Q; Liu X; Liao J; Peng Z; Wu X; Li C; Feng X
Acta Haematol; 2023; 146(6):517-521. PubMed ID: 37634507
[TBL] [Abstract][Full Text] [Related]
7. [Health status and quality of life in β-thalassemia adults in Marseille, France].
Soubrier C; Jean E; De Sainte Marie B; Agouti I; Seguier J; Lavoipierre V; Clapasson C; Iline N; Gonin J; Giorgi R; Schleinitz N; Thuret I; Badens C; Bernit E
Rev Med Interne; 2024 Apr; 45(4):187-193. PubMed ID: 38519305
[TBL] [Abstract][Full Text] [Related]
8. Can biomarkers predict myocardial iron overload in children with thalassemia major?
Karakaş H; Eroğlu AG; Akyel NG; Çığ G; Adaletli İ; Özdemir GN; Türkkan E; Celkan TT
Cardiol Young; 2023 Nov; 33(11):2203-2208. PubMed ID: 36606531
[TBL] [Abstract][Full Text] [Related]
9. CHMMOTv1 - cardiac and hepatic multi-echo (T2
Abedi I; Zamanian M; Bolhasani H; Jalilian M
BMC Res Notes; 2023 Nov; 16(1):339. PubMed ID: 37974290
[TBL] [Abstract][Full Text] [Related]
10. Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.
Chow LC; Lee BS; Tang SO; Loh EW; Ng SC; Tan XY; Ahmad Noordin MN; Ong GB; Chew LC
Med J Malaysia; 2024 May; 79(3):281-287. PubMed ID: 38817060
[TBL] [Abstract][Full Text] [Related]
11. Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.
Meloni A; Pistoia L; Ricchi P; Bagnato S; Longo F; Messina G; Bagnato S; Rossi V; Renne S; Righi R; Fina P; Positano V; Cademartiri F
Ann Hematol; 2024 Jun; 103(6):1887-1896. PubMed ID: 38581547
[TBL] [Abstract][Full Text] [Related]
12. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.
Wood JC; Otto-Duessel M; Aguilar M; Nick H; Nelson MD; Coates TD; Pollack H; Moats R
Circulation; 2005 Jul; 112(4):535-43. PubMed ID: 16027257
[TBL] [Abstract][Full Text] [Related]
13. Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.
Kirk P; Sheppard M; Carpenter JP; Anderson L; He T; St Pierre T; Galanello R; Catani G; Wood J; Fucharoen S; Porter JB; Walker JM; Forni GL; Pennell DJ
J Cardiovasc Magn Reson; 2017 Mar; 19(1):36. PubMed ID: 28343449
[TBL] [Abstract][Full Text] [Related]
14. The correlation of cardiac biomarkers and myocardial iron overload based on T2* MRI in major beta-thalassemia.
Saadatifar H; Niayeshfar A; Mard-Soltani M; Bahrampour E; Khalili S; Alinezhad Dezfuli D; Pouriamehr S
Int J Cardiovasc Imaging; 2022 Apr; 38(4):833-840. PubMed ID: 34727252
[TBL] [Abstract][Full Text] [Related]
15. [Influencing factors of iron metabolism assessment in patients with myelodysplastic syndrome: A retrospective study].
Zhang Y; Xiao C; Li J; Song LX; Zhao YS; Zhao JG; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):293-299. PubMed ID: 35680627
[No Abstract] [Full Text] [Related]
16. Growth and endocrinopathies among children with β-Thalassemia major treated at Dubai Thalassemia centre.
Almahmoud R; Hussein A; Khaja FA; Soliman AF; Dewedar H; Shareef ZA; Mathai S
BMC Pediatr; 2024 Apr; 24(1):244. PubMed ID: 38580952
[TBL] [Abstract][Full Text] [Related]
17. Aortic elasticity changes in thalassemia due to heart and liver iron deposition.
Noori NM; Teimouri A
Caspian J Intern Med; 2023; 14(3):460-469. PubMed ID: 37520866
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-Analysis of Stature Growth Complications in β-thalassemia Major Patients.
Arab-Zozani M; Kheyrandish S; Rastgar A; Miri-Moghaddam E
Ann Glob Health; 2021 Jun; 87(1):48. PubMed ID: 34164261
[TBL] [Abstract][Full Text] [Related]
19. Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study.
Musallam KM; Barella S; Origa R; Ferrero GB; Lisi R; Pasanisi A; Longo F; Gianesin B; Forni GL;
Ann Hematol; 2024 Mar; ():. PubMed ID: 38503936
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Magnesium Level with Cardiac and Hepatic Hemosiderosis Measured by T2*MRI Technique and Age in Patients with Thalassemia Major.
Ghasemi A; Ghaffari K; Hoseini F; Eghbali A; Sajadei N; Falahati V; Ghandi Y
Int J Hematol Oncol Stem Cell Res; 2023 Oct; 17(4):224-230. PubMed ID: 38076774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
